UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry

Arthritis care & research (2010), 2015-11, Vol.67 (11), p.1529-1535

2015

Volltextzugriff (PDF)

Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry

Arthritis research & therapy, 2017-11, Vol.19 (1), p.256-256, Article 256

2017

Volltextzugriff (PDF)

Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry

Arthritis research & therapy, 2020-10, Vol.22 (1), p.1-258, Article 258

2020

Volltextzugriff (PDF)

Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany

Arthritis research & therapy, 2020-04, Vol.22 (1), p.81-81, Article 81

2020

Volltextzugriff (PDF)

Baricitinib in therapy of COPA syndrome in a 15-year-old girl

European journal of rheumatology, 2020-02, Vol.7 (Suppl1), p.S78-81

2020

Volltextzugriff (PDF)

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry

Rheumatology international, 2021-04, Vol.41 (4), p.751-762

2021

Volltextzugriff (PDF)

Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity

BMC rheumatology, 2019-01, Vol.3 (1), p.4-4, Article 4

2019

Volltextzugriff (PDF)

The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON)

Arthritis research & therapy, 2018-05, Vol.20 (1), p.106-106, Article 106

2018

Volltextzugriff (PDF)

Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort

Arthritis research & therapy, 2018-12, Vol.20 (1), p.276-276, Article 276

2018

Volltextzugriff (PDF)

German guidelines for the diagnosis and therapy of localized scleroderma

Journal der Deutschen Dermatologischen Gesellschaft, 2016-02, Vol.14 (2), p.199-216

2016

Volltextzugriff (PDF)

Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry

Rheumatology (Oxford, England), 2020-09, Vol.59 (9), p.2287-2298

2020

Volltextzugriff (PDF)

Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis

Arthritis research & therapy, 2021-04, Vol.23 (1), p.118-118, Article 118

2021

Volltextzugriff (PDF)

Outcome of adult patients with JIA treated with the biosimilar Benepali ® : results of the biologic register JuMBO

Arthritis research & therapy, 2022-12, Vol.24 (1), p.271-271, Article 271

2022

Volltextzugriff (PDF)

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial

Arthritis research & therapy, 2019-05, Vol.21 (1), p.125-125, Article 125

2019

Volltextzugriff (PDF)

Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis

European journal of rheumatology, 2022-10, Vol.9 (4), p.197-205

2022

Volltextzugriff (PDF)

Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study

Pediatric rheumatology online journal, 2022-11, Vol.20 (1), p.100-100, Article 100

2022

Volltextzugriff (PDF)

Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry

Arthritis care & research (2010), 2017-04, Vol.69 (4), p.552-560

2017

Volltextzugriff (PDF)

Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review

Pediatric rheumatology online journal, 2023-02, Vol.21 (1), p.20-20, Article 20

2023

Volltextzugriff (PDF)

Treatment Patterns in Polyarticular Juvenile Idiopathic Arthritis: A Retrospective Observational Health Claims Data Study

Life (Basel, Switzerland), 2024-06, Vol.14 (6), p.712

2024

Volltextzugriff (PDF)

Biologic-Associated Infections in Pediatric Rheumatology

Current rheumatology reports, 2015-11, Vol.17 (11), p.66-66, Article 66

Horneff, Gerd

2015

Volltextzugriff (PDF)

Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany

Pediatric rheumatology online journal, 2018-01, Vol.16 (1), p.7-7, Article 7

2018

Volltextzugriff (PDF)

S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 2

Journal der Deutschen Dermatologischen Gesellschaft, 2019-09, Vol.17 (9), p.959-973

2019

Volltextzugriff (PDF)

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Journal of clinical immunology, 2022-04, Vol.42 (3), p.500-511

2022

Volltextzugriff (PDF)

Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis

Pediatric rheumatology online journal, 2017-11, Vol.15 (1), p.78-78, Article 78

2017

Volltextzugriff (PDF)

Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND initiative

Pediatric rheumatology online journal, 2020-02, Vol.18 (1), p.17-17, Article 17

2020

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(153)

Publikationsform

Artikel
(188)

Sprache

Englisch
(183)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(188)
Rheumatology
(146)
Humans
(133)
Child
(97)
Male
(84)
Female
(83)
Adolescent
(82)
Arthritis, Juvenile - Drug Therapy
(74)
Juvenile Idiopathic Arthritis
(61)
Arthritis
(58)
Child, Preschool
(54)
Pediatrics
(51)
Antirheumatic Agents - Therapeutic Use
(50)
Treatment Outcome
(50)
Patients
(45)
Biological And Medical Sciences
(36)
Medical Sciences
(35)
Etanercept
(34)
Registries
(26)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry

Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry

Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry

Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany

Baricitinib in therapy of COPA syndrome in a 15-year-old girl

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry

Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity

The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON)

Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort

German guidelines for the diagnosis and therapy of localized scleroderma

Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry

Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis

Outcome of adult patients with JIA treated with the biosimilar Benepali ® : results of the biologic register JuMBO

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial

Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis

Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study

Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry

Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review

Treatment Patterns in Polyarticular Juvenile Idiopathic Arthritis: A Retrospective Observational Health Claims Data Study

Biologic-Associated Infections in Pediatric Rheumatology

Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany

S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 2

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis

Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND initiative

Aktive Filter

Suchergebnisse filtern